These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25356753)

  • 1. Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
    Feng J; Xu L; Ni S; Gu J; Zhu H; Wang H; Zhang S; Zhang W; Huang J
    Oncotarget; 2014 Oct; 5(20):9689-702. PubMed ID: 25356753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
    Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
    Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.
    Feng J; Zhang X; Zhu H; Wang X; Ni S; Huang J
    PLoS One; 2012; 7(6):e39937. PubMed ID: 22761930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.
    He Y; Xie H; Yu P; Jiang S; Wei L
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1049-1059. PubMed ID: 30302523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients.
    Wang Y; Wen L; Zhao SH; Ai ZH; Guo JZ; Liu WC
    Lung Cancer; 2013 Feb; 79(2):173-9. PubMed ID: 23177020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.
    Li L; Xu B; Zhang H; Wu J; Song Q; Yu J
    J Clin Lab Anal; 2020 Jan; 34(1):e23031. PubMed ID: 31713908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer.
    Del Bufalo D; Desideri M; De Luca T; Di Martile M; Gabellini C; Monica V; Busso S; Eramo A; De Maria R; Milella M; Trisciuoglio D
    Mol Cancer; 2014 Oct; 13():230. PubMed ID: 25301686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
    Chen Y; Yang S; Zhou H; Su D
    Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
    Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
    Zhu X; Li D; Yu F; Jia C; Xie J; Ma Y; Fan S; Cai H; Luo Q; Lv Z; Fan L
    Oncotarget; 2016 Mar; 7(11):13139-52. PubMed ID: 26909612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT.
    Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J
    J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
    Guo J; Jin D; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Miao S; Xi S
    EBioMedicine; 2018 Sep; 35():204-221. PubMed ID: 30146342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
    Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
    [No Abstract]   [Full Text] [Related]  

  • 17. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.
    Zhang X; Wang L; Wang Y; Shi S; Zhu H; Xiao F; Yang J; Yang A; Hao X
    Oncol Rep; 2016 Oct; 36(4):2349-56. PubMed ID: 27573292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
    Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
    Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
    Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.